Atrial Fibrillation (AFib) clinical trials
Showing 101–135 of 135 active trials. Describe your situation to see which ones look like a fit.
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation
- Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
- The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
- EPX-HTG for Structural Heart Procedures
- BOdygUardian MOnitoriNg for ReCurrencE of AF
- MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
- Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- MCG In Long QT Syndrome
- Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
- Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study
- Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
- Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction
- Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
- Subspecialty Ambulatory Quality Cardiology Program
- Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
- KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation
- Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool
- Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
- Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation
- Atrial Fibrillation Risk Estimation With Single-lead Handheld Electrocardiograms
- Comparing Surgical Management Methods of Atrial Fibrillation
- Developing MRI Technologies for Atrial Fibrillation
- Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation
- A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
- Health eHeart BEAT-AFib - Health eHeart Biomarkers of Early Atrial Transformation in Atrial Fibrillation
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- Quest to Analyze One Thousand Humans Meditating
- Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
- A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
- ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
- Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
- Warfarin Patient Self-management Implementation in the US Healthcare System
- The Z Stitch Early Bed Rest Assessment Study
- P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation
- Concomitant LAAC/AF Ablation (Watchman FLX Pro)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.